← Leaderboards
Kamal D. Moudgil
Baltimore Va Medical Center
$4,222,813
Attributed
$4,222,813
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $450K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,222,813 · 11
VA$0 · 3
By mechanism
R21$2,052,172 · 6
R01$1,799,636 · 2
R03$371,005 · 3
I01$0 · 1
I21$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteArthritisAntibodiesRattusOrganIn VivoRheumatoid ArthritisAutoimmunityInflammation MediatorsTissuesMigrationPharmaceutical PreparationsToxic EffectReportingPathogenesisAdjuvant ArthritisCellsInnovationAffectChronicAdverse ReactionsDesignAdverse EffectsJoints
Grant awards (32)
Validation of the disease-protective effects of pristimerin in EAE models with complementary characteristics$0
I21 · FY2025 · VA · contact PI
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model$0
I21 · FY2025 · VA · contact PI
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model$0
I21 · FY2024 · VA · contact PI
Identification of eye-homing peptides and their use for targeted liposomal drug delivery in posterior uveitis$193,125
R21 · FY2023 · EY · contact PI
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model$0
I21 · FY2023 · VA · contact PI
Identification of eye-homing peptides and their use for targeted liposomal drug delivery in posterior uveitis$231,750
R21 · FY2022 · EY · contact PI
Anti-arthritic activity and therapeutic use of novel joint-homing peptides$0
I01 · FY2018 · VA · contact PI
Anti-arthritic activity and therapeutic use of novel joint-homing peptides$0
I01 · FY2017 · VA · contact PI
Anti-arthritic activity and therapeutic use of novel joint-homing peptides$0
I01 · FY2016 · VA · contact PI
Defining glomerulus-homing peptides for targeted drug delivery in lupus nephritis$230,250
R21 · FY2015 · AI · contact PI
Anti-arthritic activity and therapeutic use of novel joint-homing peptides$0
I01 · FY2015 · VA · contact PI
Defining glomerulus-homing peptides for targeted drug delivery in lupus nephritis$191,875
R21 · FY2014 · AI · contact PI
Identification of CNS-homing peptides for therapeutic use in multiple sclerosis$189,956
R21 · FY2014 · NS · contact PI
Identification of CNS-homing peptides for therapeutic use in multiple sclerosis$230,250
R21 · FY2013 · NS · contact PI
Immune Modulation of Autoimmunity by Herbal Products$367,538
R01 · FY2012 · AT · contact PI
Immune Modulation of Autoimmunity by Herbal Products$367,538
R01 · FY2011 · AT · contact PI
Immune Modulation of Autoimmunity by Herbal Products$371,250
R01 · FY2010 · AT · contact PI
Immune Modulation of Autoimmunity by Herbal Products$375,000
R01 · FY2009 · AT · contact PI
Cellular therapy of autoimmunity using antigen-expressing B cells$75,000
R03 · FY2009 · AI · contact PI
Cellular therapy of autoimmunity using antigen-expressing B cells$75,000
R03 · FY2008 · AI · contact PI
Modulation of Autoimmunity by Green Tea Polyphenols$161,686
R21 · FY2006 · AT · contact PI
REGULATION OF AUTOIMMUNITY THROUGH EPITOPE SPREADING$72,505
R03 · FY2006 · AI · contact PI
Modulation of Autoimmunity by Green Tea Polyphenols$177,780
R21 · FY2005 · AT
REGULATION OF AUTOIMMUNITY THROUGH EPITOPE SPREADING$74,250
R03 · FY2005 · AI
PROFILING SYNOVIAL VASCULATURE IN ARTHRITIS-PRONE RATS$74,250
R21 · FY2005 · AR
PROFILING SYNOVIAL VASCULATURE IN ARTHRITIS-PRONE RATS$74,250
R21 · FY2004 · AR
SELF-DETERMINANTS &INDIRECTION OF ANTI-SELF IMMUNITY$161,506
R01 · FY2001 · AI
IMMUNOLOGIC BASIS ENIVR MODULATION OF AUTOIM ARTHRITIS$148,500
R21 · FY2001 · AI
SELF-DETERMINANTS &INDIRECTION OF ANTI-SELF IMMUNITY$156,804
R01 · FY2000 · AI
IMMUNOLOGIC BASIS ENIVR MODULATION OF AUTOIM ARTHRITIS$148,500
R21 · FY2000 · AI
REGULATION OF AUTOIMMUNITY BY MODULATING ANTIGEN PROCESS$59,237
R03 · FY2000 · AR
REGULATION OF AUTOIMMUNITY BY MODULATING ANTIGEN PROCESS$15,013
R03 · FY2000 · AR